Online Registration opens Abstract Submission opens Abstract Submission Deadline Late Breaking Abstract Submission Deadline Early Registration Deadline

　http://jsmo2012.umin.jp/en/

For frequent updates please visit↓

Important DatesFebruary, 2011

December 21, 2011 February 8, 2012May 18, 2012June, 2012

1st Announcement & Call for Papers

( OICC GRAND CUBE OSAKA)Osaka International Convention CenterVenue:

Congress President: Kazuhiko Nakagawa(Department of Medical Oncology, Kinki University Faculty of Medicine)

July26-28,2012July26-28,2012

Congress PresidentKazuhiko Nakagawa

Congress President, 10th Annual Meeting of JSMO,

Professor, Department of Medical Oncology,

Kinki University Faculty of Medicine

We express our deepest sympathy to all who were stricken by the recent Great East Japan Earthquake in March 2011.On behalf of the Japanese Society of Medical Oncology（JSMO）, we are pleased to invite you to the 10th Annual Meeting of JSMO with the theme of "Beyond the Global Standard of Medical Oncology ~Perspectives from Asia~".This conference will draw together many specialists in medical oncology from a wide range of disciplines from all over the world. More than 5,000 people are expected to join this event. The 10th Annual Meeting of JSMO will be of great international flavor. The following features are some of the new attempts.

1.　Calling for paper abstracts from overseas （particularly from the Asian district）2.　International Session, which was initiated by the 9th Annual Meeting of JSMO, will be continued this year, by inviting many speakers from around the world.3.　English translation will be provided in all of more than 30 　　 educational sessions, and English Slides will be used in 　 these sessions.4.　Joint-Symposiums with the world's leading scientific organi zations such as ASCO, ESMO, CSCO and KACO.

We will update the details of the program as needed. This confer-ence will certainly provide a wonderful forum to enrich and refresh your knowledge base and serve for your advancement in the field of the cancer treatment.We look forward to welcoming you in Osaka.

2

Welcome Message

The10th Annual Meeting of Japanese Society of Madical �cology

Program Committee

Secretary General

Congress President

Isamu Okamoto Kinki University, Japan

Hirotoshi Akita Hokkaido University, Japan

Ann-Lii Cheng National Taiwan University, Taiwan

Hyun Cheol Chung Yonsei University College of Medicine, KoreaYasuhito Fujisaka Kinki University, JapanMasahiro Fukuoka Izumi Municipal Hospital, JapanChikashi Ishioka Tohoku University, Japan

YH Kim Korea University, KoreaNaomi Kiyota Kobe University, JapanMasatoshi Kudo Kinki University, JapanTakayasu Kurata Kinki University, Japan

Koji Matsumoto Hyogo Cancer Center, JapanItaru Matsumura Kinki University, JapanYoo Hong Min Yonsei University, KoreaHironobu Minami Kobe University, JapanMasaki Miyazaki Kinki University, JapanTony Mok The Chinese University of Hong Kong, Hong KongKazuhiko Nakagawa Kinki University, Japan

Kazuhiko Nakagawa Kinki University, Japan

Kazuomi Ueshima Kinki University, Japan

Yasumasa Nishimura Kinki University, Japan

Kinki University, JapanIsamu OkamotoKeunchil Park Sungkyunkwan University, Korea

Kinki University, JapanNagahiro SaijoTaroh Sato Osaka University, Japan

Kinki University, JapanTamaki Shin

Minoru Takada Sakai Hospital Kinki University, JapanKoji Takeda Osaka City General Hospital, Japan

Takao Tamura Nara Hospital Kinki University, JapanJunji Tsurutani Kinki University, JapanAkihiro Tokoro Kinki-Chuo Chest Medical Center

Kinki University, JapanShinya Ueda

Yi-Long Wu Guangdong General Hospital, China

Hisateru Yasui Kyoto Medical Center, JapanKimio Yonesaka Izumi Municipal Hospital, Japan

Kinki University, JapanKazuto Nishio

Yung-Jue Bang Seoul National University Hospital, KoreaAnthony T.C. Chan The Chinese University of Hong Kong, Hong KongSai-Juan Chen Shanghai Jiao Tong University, China

Chor Sang Chim Queen Mary Hospital, Hong Kong

Yoon-Koo Kang Asan Medical Center, University of Ulsan, Korea

Je-Hwan Lee Asan Medical Center, KoreaJin Li Fudan University Cancer Hospital, China

Shu-Kui Qin PLA Cancer Center, China

Cheolwon Suh University of Ulsan, Korea

Kazuo Tamura Fukuoka University, Japan

James Yang National Taiwan University, Taiwan

Conference Officers

The10th Annual Meeting of Japanese Society of Madical �cology

3

Yung-Jue Bang Seoul National University Hospital, KoreaJose Baselga Massachusetts General Hospital, USAAnthony T.C. Chan The Chinese University of Hong Kong, Hong KongSai-Juan Chen Shanghai Jiao Tong University, ChinaAnn-Lii Cheng National Taiwan University, TaiwanChor Sang Chim Queen Mary Hospital, Hong KongHyun Cheol Chung Yonsei University College of Medicine, KoreaLuca Gianni San Raffaele Institute, ItalyPasi A. Janne Dana-Farber Cancer Institute, USABruce E. Johnson Dana-Farber Cancer Institute, USAYoon-Koo Kang Asan Medical Center, University of Ulsan, KoreaYH Kim Korea University, KoreaJonathan Ledermann UCL Cancer Institute, EnglandJe-Hwan Lee Asan Medical Center, KoreaHeinz-Josef Lenz University of Southern California, USAJin Li Fudan University Cancer Hospital, ChinaYoo Hong Min Yonsei University, KoreaPerry Nisen Cancer Research at GlaxoSmithKline, USAKeunchil Park Sungkyunkwan University, KoreaShu-Kui Qin PLA Cancer Center, ChinaGiorgio V. Scagliotti University of Torino, ItalyCheolwon Suh University of Ulsan, KoreaSandra M. Swain Washington Cancer Institute, USAAnthony W. Tolcher South Texas Accelerated Research Therapeutics, USANaoto Ueno The University of Texas MD Anderson Cancer Center, USAJ.B. Vermorken Antwerp University Hospital, BelgiumEverett E. Vokes University of Chicago, USAYi-Long Wu Guangdong General Hospital, ChinaJames Yang National Taiwan University, Taiwan

The10th Annual Meeting of Japanese Society of Madical �cology

Foreign Invited Speakers List (tentative)

4

Abstract Submission

Submission Guidelines

Late-breaking Abstract

JSMO2012 is inviting the submission of Scientific Abstracts from overseas. Authors are asked to submit abstracts under one of the following categories:

1. Biomarker & Developmental Therapeutics2. Breast Cancer3. Head and Neck Cancer4. Lung Cancer5. Gastric Cancer6. Colorectal Cancer7. Hepato-biliary-pancreatic Cancer8. Hematological Malignancies9. Trials in Progress

Abstracts must be submitted electronically through the Conference website:http://jsmo2012.umin.jp/en/Abstract Submission opens: December 21st, 2011

Late-breaking abstracts may be submitted for studies with new research findings for which no preliminary data are available at the time of the abstract submission deadline (February 8, 2012). The authors of late-breaking abstracts need to submit the first versions, which do not have to contain the complete results, by February 8, 2012. Final versions must be submitted by May 18, 2012.

Abstract Submission Deadline: February 8th, 2012

Call for Papers

The10th Annual Meeting of Japanese Society of Madical �cology

Please go to P14 for information about Travel Award

5

Preliminary Program*Please Note: The Preliminary Program is subject to change without notice.

8:00 9:00 10:00 11:00 12:00

The10th Annual Meeting of Japanese Society of Madical �cology

Room1

Room

2,248seats

EventHall B~E1.900 ㎡

S1: The role of medical oncologists in Japan:Result of Training Program of Oncology Specialist

S4: The current situations and issues in Phase I studies in Japan

ASCO/JSMO joint-symposium:"Drug Development & Biomarker"

JCA/JAMTTC/JSMO joint-symposium:"The current situation of biomarker study in Japan"

5F

Room2

328seats5F

Room3

320seats10F 1001~2

Room5

250seats10F 1004~7

Room6

160seats10F 1008

Room7

240seats10F 1009

Room8

380seats12F 1009

Room9

160seats12F 1202

Room10

520seats3F Event HallA

Room4

480seats10F EnglishHall

Opening

ES1:Sup-portive Care

ES2:Sup-portive Care

ES3:Sup-portive Care

ES4:Breast Cancer

Special Lecture

ES5:Lung Cancer

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

W5: The current situation and future of multiple myeloma treatment

W12: Supporting the families of cancer patients

Day 1 (2012,July 26, Thu)

Exhibition Poster

ES: Educational Session　 S: Symposium　 W: Workshop 　IS: International Session

6

Preliminary Program

*Please Note: The Preliminary Program is subject to change without notice.

The10th Annual Meeting of Japanese Society of Madical �cology

13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00

Room1

Room

EventHall B~E

S2: Building the foundation for Investigator-Initiated Clinical Trial

S5:The progress of individualized-therapy by biomarker

S12: HCC: New treatment strategy

S3: The role of CRC in clinical trials in the time of globalization

IS6: Hepato-biliary-pancreatic

President's Symposium 1:New anti-cancer drug development in Japan and its new prospect

JPOS/JSMO joint-symposium:"Psycho-oncology support and communication in cancer treat-ment"

5F

Room2 5F

Room310F 1001~2

Room510F 1004~7

Room610F 1008

Room710F 1009

Room812F1009

Room912F 1202

Room103F

Event HallA

Room410F

EnglishHall

ES16:Pallia-tive Care

ES8:HCC

ES9:Hema-to--poietic organ

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

W2: Head & Neck, Esophageal cancer treatment strategy

W3:New drugs for gastric cancer

S14:Supportive care aiming for effective drug therapy

S8: New developments in immunotherapy focusing on peptide vaccine

Day 1 (2012,July 26, Thu)

Exhibition Poster

10th Anniversary of JSMO: History of Medical Oncology in Japan

Public Symposium:Community-based coopera-tion that cancer patients need

ES17:Pallia-tive Care

IS2: Breast Casncer IS9: Trials in ProgressIS5: Gastric Cancer

ES: Educational Session　 S: Symposium　 W: Workshop 　IS: International Session

7

Preliminary Program

*Please Note: The Preliminary Program is subject to change without notice.

7:00 8:00 9:00 10:00 11:00 12:00

The10th Annual Meeting of Japanese Society of Madical �cology

Room

S10: Rationalization of anti-angiogenic therapy

S11: The progress of cancer treatment targetting on HER2

W4: Colorectal Cancer -New direction-

W1: Palliative Care Clinical Trials

IS8:Hematological Malignancies

IS1:Biomarker & Developmental Therapeutics

JASTRO/JSMO joint-symposium:"The role of molecular-targeted therapy in radiotherapy"

ES10:Drug interac-tion

ES11:Basics

ES12:Ad-vanced Therapy

ES20:Head&Neck

ES14:Surgical Treat-ment

ES15: Pleural Perito-nealCarcino-ma-tosis

ES7:Colorec-tal Cancer

JSMO Diplomate Assembly

JSMO Diplomate Case Conference

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

W10: Individualization of breast cancer treatment

W9: The progress in lung cancer treatment

S7: New molecular target drug and clinical trials-The current trend-

Day 2 (2012,July 27, Fri)

Exhibition Poster

Room1

EventHall B~E

5F

Room2 5F

Room310F 1001~2

Room510F 1004~7

Room610F 1008

Room710F 1009

Room812F1009

Room912F 1202

Room103F

Event HallA

Room410F

EnglishHall

ES: Educational Session　 S: Symposium　 W: Workshop IS: International Session

8

Preliminary Program

*Please Note: The Preliminary Program is subject to change without notice.

The10th Annual Meeting of Japanese Society of Madical �cology

13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00

Room1

Room

EventHall B~E

S6: Overcoming resistance of molecular target drug

JSH/JSMO joint-symposium:"The characteristics and clinical significance of cancer stem cell"

ESMO/JSMO joint-symposium:"EGFR Inhibition & Anti-EGFR Therapy"

5F

Room2 5F

Room310F 1001~2

Room510F 1004~7

Room610F 1008

Room710F 1009

Room812F1009

Room912F 1202

Room103F

Event HallA

Room410F

EnglishHall

ES18:Bio-mark-er

ES13:Radia-tion Thera-py

ES19:Clinical Trials

Evening Seminar

Evening Seminar

Evening SeminarFilm "Living Proof"

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

Evening Seminar

S13: The progress in palliative care after the Cancer Control Act and its future direction

Exhibition Poster

General Assem-bly

Invited Lecture 1

ES6:Gastric Cancer

Day 2 (2012,July 27, Fri)

Plenary Session

W8: Effective chemtherapy structure by team medicine

ES: Educational Session　 S: Symposium　 W: Workshop IS: International Session

9

Preliminary Program

*Please Note: The Preliminary Program is subject to change without notice.

8:00 9:00 10:00 11:00 12:00

The10th Annual Meeting of Japanese Society of Madical �cology

Room

S15: The expectation towards EML4-ALK inhibitor

W7: The Endpoint of Phase 3 trials-OS or PFS?-

W6: Clinical features and treatment of malignant lymphoma

IS7: Colorectal Cancer IS4: Head & Neck Cancer

JBCS/JSMO joint-symposium:"Breast cancer treatment strategy from biological perspective"

ES21:Esopha-gealCancer

ES22:Hepatobil-iary pancreatic cancer

ES23:Gyneco-logic Cancer

ES25:Sarcoma

ES26:Skin Cancer

ES27:Unknown primary

ES24:Urologic Cancer

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

Luncheon Seminar

W15: New treatment strategy for urologic cancer

W13: Rehabilitaion of cancer patients

CSCO/KACO/JSMO joint-symposium:"Progress of INDTs & IITs in the Asian Countries"

Day 3 (2012,July28,Sat )

Exhibition Poster

Room1

EventHall B~E

5F

Room2 5F

Room310F 1001~2

Room510F 1004~7

Room610F 1008

Room710F 1009

Room812F1009

Room912F 1202

Room103F

Event HallA

Room410F

EnglishHall

Invited Lecture 2

W14: Effective community-based cooperation

ES: Educational Session　 S: Symposium　 W: Workshop IS: International Session

10

Preliminary Program

*Please Note: The Preliminary Program is subject to change without notice.

The10th Annual Meeting of Japanese Society of Madical �cology

13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00

Room1

Room

EventHall B~E

S16: How to use anti-cancer drug rationally

S9: New developments in anti-EGFR therapy in solid cancer

President's Symposium 2:The dawning of Medical Oncology and the develop-ment of Internal Medicine

5F

Room2 5F

Room310F 1001~2

Room510F 1004~7

Room610F 1008

Room710F 1009

Room812F1009

Room912F 1202

Room103F

Event HallA

Room410F

EnglishHall

ES28:Endo-crine Tumor

ES29:Hepati-tus B Virus

ES30:Anti-cancer agents -skin disor-

ES31:Anti-cancer agents adjust-ment

ES32:PK/PD of Molecular-target drug

Party at the Hotel

W11: Cervical cancer contermeasure

Day 3 (2012,July 28, Sat)

Exhibition Poster

Public Lectures

Close-ing

IS3: Lung Casncer

ES: Educational Session　 S: Symposium　 W: Workshop IS: International Session

11

1. Biomarker & Developmental Therapeutics2. Breast Cancer3. Lung Cancer4. Head & Neck Cancer 5. Gastric Cancer 6. Hepato-biliary-pancreatic Cancer 7. Colorectal Cancer 8. Hematological Malignancies9. Trials in Progress

● More than 30 educational lectures● English translation will be provided in all educational sessions

3. Supportive Care3: How to choose antiemetics

5. Lung Cancer: Driver oncogene & drug therapy

8. HCC: Molecular-targeting drug therapy

9. Hematopoietic organ malignant disease

10. Drug interaction of anticancer agents

11. Basic: Searching a new molecular target

13. Radiation Therapy: Cutting-edge IMRT

15. Malignant pleural and peritoneal carcinoma tosis treatment

14. Surgical Treatment: Comparative study of mulitiple- facilities randomization

12. Advanced Therapy: New treatment development based 　　on cancer stem cell theory

7. Colorectal Cancer: The latest evidences in drug therapy

6. Gastric Cancer: The latest evidences in drug therapy

4. Breast Cancer: The latest evidences in drug therapy

2. Supportive Care2: New development on bone metastasis treatment

1. Supportive Care1: Diagnostic treatment of drug-induced interstitial pneumonia

International Sessions

Educational Sessions with English Translation

Program Highlights

The10th Annual Meeting of Japanese Society of Madical �cology

12

・ASCO/JSMO: "Drug Development & Biomarker"・ESMO/JSMO: "EGFR Inhibition & Anti-EGFR therapy"・CSCO/KACO/JSMO: "Progress of INDTs (Investigational New Drug Trials) and IITs (Investigator Initiated Trials) in the Asian countries"

16. Palliative Care: IVR in palliative care for cancer

17. Palliative Care based on EBM

19. Clinical Trial: Interpretation of methods and results

20. Head & Neck Cancer drug therapy

22. Hepatobiliary Pancreatic Cancer: Cutting-edge drug therapy

30. How to overcome skin disorder caused by anticancer agents

31. Issues occurring in adjustment of anticancer agents

32. PK/PD of molecular-targeting drug

27. Cancers of unknown primary: Drug therapy -Latest Findings-

21. Esophageal Cancer drug therapy

23. Gynecologic Cancer: Ovarian cancer drugtherapy

24. Urologic Cancer drug therapy

25. Sarcoma: Molecular-targeting therapy

26. Skin Cancer: Drug therapy for malignant melanoma

28. Endocrine Tumor: Molecular-targeting therapy for PNET

29. How to overcome the reactivation of hepatitus B virus caused by cancer treatment

18. Biomarker: Search of biomarker

Joint-Symposiums with ASCO, ESMO, CSCO and KACO

Educational Sessions with English Translation

The10th Annual Meeting of Japanese Society of Madical �cology

13

● To qualify, applicants must currently live in the Asian countries (except for Japan) 　or be U.S. citizens or E.U. citizens.● If you are already getting financial support from any company or society, your application will be removed from recipient lists.

Among the titles submitted to the 10th Annual Meeting of the Japanese Society of Medical Oncology, those submitted by the researchers living in other coun-tries than Japan will be reviewed by a selection committee. The travel expenses of presenters who have submitted outstanding work will partially be refunded.

US$600~1200 of travel support to 100 Investigators from AsiaUS$1900 of travel support to 20 Investigators from US or EU(The amount of travel support may be changed accordingly depending on the place the applicants live in.)

● Submit paper abstract through JSMO2012 website.● When you're submitting abstract, you will be asked whether you want to apply 　for Travel Award or not on the first page of online abstract submission proce- dure.● The Selection Committee members will evaluate their submitted abstracts com-　prehensively based on the study contents, ethical aspects to select who would be appropriate for this award.● Every investigator whose abstract is accepted in International Session (English oral presentation), will be a recipient of Travel Award. However, Travel Award is 　not limited only to International Sessions. It is open to any abstract submitted from overseas including poster presentations as well.

1. What is Travel Award?

2. What's included in Travel Award?

3. How to apply for Travel Award?

Travel Award

The10th Annual Meeting of Japanese Society of Madical �cology

14

Department of Medical Oncology, Kinki University Faculty of Medicine377-2, Ohno-higashi, Osakasayama City, Osaka, 589-8511, JAPAN

Organized by:

Contact to Secretariat of 10th JSMO:Sunplanet Medical Convention2-3-6, Kitahama, Chuou-ku, Osaka City, Osaka, 541-0041, JAPANEmail: jsmo2012@sunpla-mcv.com

Access

Contacts

Osaka International Convention Center

Location: 5-3-51, Nakanoshima Kita-ku, Osaka 530-0005 JAPAN

Tel: 06-4803-5555

For more detailsabout Osaka International Convention Center↓http://www.gco.co.jp/en/

Osaka International Convention Center

The10th Annual Meeting of Japanese Society of Madical �cology

　http://jsmo2012.umin.jp/en/

For frequent updates please visit↓

15

http://jsmo2012.umin.jp/en/